Neuromuscular Blocker [EPC]

Neuromuscular Blocker [EPC] was reported 99109 times

Drugs of the Neuromuscular Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MEPHISTO SIGN 68 0.9577
1 BROW PTOSIS 614 0.9360
2 BOTULISM 710 0.8575
3 NEUROMUSCULAR TOXICITY 206 0.5852
4 MULTIPLE USE OF SINGLE-USE PRODUCT 2869 0.5105
5 HEPATIC ENZYME 75 0.5034
6 EYELID SENSORY DISORDER 76 0.3858
7 EYELID PTOSIS 3817 0.3752
8 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 37 0.3558
9 FACE LIFT 22 0.3548
10 FACIAL ASYMMETRY 338 0.3543
11 FACIAL PARESIS 1032 0.2914
12 LAGOPHTHALMOS 95 0.2323
13 POSTNATAL GROWTH RESTRICTION 30 0.2290
14 FACET JOINT SYNDROME 746 0.2289
15 NEOVASCULARISATION 60 0.2281
16 PRODUCT PREPARATION ERROR 4403 0.2141
17 VASCULAR MALFORMATION 43 0.2048
18 RESIDUAL URINE VOLUME INCREASED 24 0.2034
19 HYPOCHOLESTEROLAEMIA 70 0.1983
20 DERMATOCHALASIS 28 0.1905
21 PARANASAL CYST 44 0.1811
22 CERVICOGENIC HEADACHE 24 0.1765
23 PRODUCT PREPARATION ISSUE 1145 0.1744
24 BLEPHAROSPASM 1051 0.1667
25 OVERLAP SYNDROME 115 0.1643
26 PERIPHERAL VENOUS DISEASE 638 0.1561
27 INJECTION SITE GRANULOMA 33 0.1392
28 SKIN WRINKLING 366 0.1345
29 ONYCHOMADESIS 563 0.1340
30 FACIAL DISCOMFORT 93 0.1312
31 SKIN INDENTATION 59 0.1250
32 BREAST CANCER STAGE III 802 0.1237
33 RHEUMATIC FEVER 548 0.1228
34 LID SULCUS DEEPENED 42 0.1126
35 SWOLLEN JOINT COUNT 28 0.1120
36 DUODENAL ULCER PERFORATION 793 0.1065
37 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 719 0.1003
38 ONYCHOMYCOSIS 423 0.0963
39 THERAPEUTIC RESPONSE DECREASED 5305 0.0874
40 MUSCLE HYPERTROPHY 30 0.0855
41 MUSCLE INJURY 680 0.0820
42 INFUSION SITE REACTION 242 0.0809
43 CUTIS LAXA 22 0.0809
44 PATIENT DISSATISFACTION WITH TREATMENT 155 0.0804
45 LUPUS VULGARIS 101 0.0802
46 FACIAL SPASM 89 0.0795
47 MIGRAINE WITHOUT AURA 23 0.0767
48 FOLLICULITIS 800 0.0762
49 LIVE BIRTH 625 0.0746
50 HELICOBACTER INFECTION 765 0.0744
51 NAIL DISORDER 640 0.0731
52 FINGER DEFORMITY 354 0.0730
53 LIP DRY 663 0.0729
54 POST-TRAUMATIC NECK SYNDROME 58 0.0717
55 PRODUCT ADMINISTERED BY WRONG PERSON 27 0.0707
56 SKIN TIGHTNESS 330 0.0701
57 INJECTION SITE OEDEMA 118 0.0686
58 BURSITIS 825 0.0679
59 HYPERCHOLESTEROLAEMIA 653 0.0676
60 OCCIPITAL NEURALGIA 38 0.0673
61 PEMPHIGUS 837 0.0669
62 WOUND INFECTION 718 0.0655
63 EXTRAOCULAR MUSCLE PARESIS 30 0.0654
64 DRUG SPECIFIC ANTIBODY 89 0.0650
65 C-REACTIVE PROTEIN 60 0.0647
66 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35 0.0624
67 SKIN LAXITY 27 0.0616
68 C-REACTIVE PROTEIN ABNORMAL 393 0.0612
69 INCORRECT PRODUCT FORMULATION ADMINISTERED 54 0.0610
70 X-RAY ABNORMAL 107 0.0598
71 SOFT TISSUE INJURY 45 0.0594
72 HAND DEFORMITY 778 0.0593
73 DISLOCATION OF VERTEBRA 135 0.0591
74 FACIAL PARALYSIS 492 0.0577
75 GRIP STRENGTH DECREASED 505 0.0573
76 EYELID FUNCTION DISORDER 45 0.0569
77 INJECTION SITE HYPOAESTHESIA 81 0.0566
78 DEEP VEIN THROMBOSIS POSTOPERATIVE 113 0.0564
79 PRODUCT LABEL CONFUSION 328 0.0562
80 PERIORBITAL SWELLING 311 0.0549
81 BACK INJURY 596 0.0547
82 HYPOAESTHESIA EYE 32 0.0542
83 JOINT RANGE OF MOTION DECREASED 685 0.0510
84 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 105 0.0506
85 INJECTION SITE PARAESTHESIA 77 0.0501
86 POOR QUALITY PRODUCT ADMINISTERED 523 0.0496
87 PERICARDITIS 827 0.0492
88 MASTICATION DISORDER 150 0.0490
89 TORTICOLLIS 102 0.0481
90 MASTOIDITIS 47 0.0479
91 REDUCED FACIAL EXPRESSION 47 0.0463
92 MANUFACTURING PRODUCT SHIPPING ISSUE 25 0.0460
93 SYNOVITIS 822 0.0455
94 EYELID DISORDER 105 0.0455
95 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1642 0.0452
96 THERAPEUTIC RESPONSE SHORTENED 1466 0.0442
97 SWOLLEN JOINT COUNT INCREASED 139 0.0435
98 COELIAC DISEASE 426 0.0434
99 EYELID OEDEMA 501 0.0431
100 FACIAL PAIN 384 0.0430
101 LIP DISORDER 81 0.0427
102 DRUG EFFECT LESS THAN EXPECTED 624 0.0421
103 PHARYNGEAL HYPOAESTHESIA 38 0.0409
104 TASTE DISORDER 812 0.0400
105 OPHTHALMOPLEGIA 62 0.0393
106 OBESITY 624 0.0391
107 THERAPEUTIC PRODUCT EFFECT DECREASED 1730 0.0386
108 RETINITIS 65 0.0376
109 PRODUCT TEMPERATURE EXCURSION ISSUE 192 0.0373
110 MIGRAINE 3563 0.0373
111 PORPHYRIA ACUTE 53 0.0369
112 SWELLING OF EYELID 232 0.0369
113 EYE CONTUSION 78 0.0369
114 BONE EROSION 130 0.0367
115 TONGUE PARALYSIS 26 0.0365
116 GLOSSODYNIA 811 0.0362
117 PRODUCT USED FOR UNKNOWN INDICATION 45 0.0357
118 STERNAL FRACTURE 44 0.0357
119 SUSPECTED PRODUCT QUALITY ISSUE 64 0.0349
120 ASTHENOPIA 190 0.0345
121 VIITH NERVE PARALYSIS 118 0.0342
122 FIBROMYALGIA 829 0.0341
123 EPILEPSY 1042 0.0341
124 HYPOAESTHESIA FACIAL 51 0.0339
125 TENSION HEADACHE 145 0.0337
126 NECK PAIN 1877 0.0336
127 IRRITABLE BOWEL SYNDROME 711 0.0331
128 CONGENITAL ANOMALY 252 0.0325
129 PERIORBITAL OEDEMA 164 0.0316
130 DIPLOPIA 766 0.0295
131 FACIAL PALSY 62 0.0287
132 ADVERSE REACTION 375 0.0283
133 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 75 0.0282
134 INJECTION SITE INDENTATION 61 0.0281
135 WOUND 774 0.0277
136 ENDOMETRIOSIS 132 0.0277
137 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 472 0.0275
138 STRABISMUS 79 0.0269
139 INJECTION SITE PAPULE 120 0.0262
140 VOCAL CORD PARALYSIS 47 0.0262
141 SENSATION OF PRESSURE 23 0.0260
142 SYSTEMIC LUPUS ERYTHEMATOSUS 919 0.0259
143 MUSCULAR WEAKNESS 2914 0.0256
144 LIVER INJURY 627 0.0255
145 DRUG INEFFECTIVE 33257 0.0252
146 TYPE 2 DIABETES MELLITUS 845 0.0251
147 DYSPHAGIA 2369 0.0249
148 POSTURE ABNORMAL 81 0.0249
149 SWELLING FACE 1617 0.0248
150 NORMAL NEWBORN 134 0.0246
151 HEAD DISCOMFORT 430 0.0243
152 BLADDER SPASM 45 0.0240
153 INJECTION SITE HYPERSENSITIVITY 75 0.0240
154 POOR QUALITY DRUG ADMINISTERED 155 0.0239
155 DARK CIRCLES UNDER EYES 35 0.0238
156 CONTRAINDICATED PRODUCT ADMINISTERED 718 0.0237
157 COUNTERFEIT PRODUCT ADMINISTERED 30 0.0230
158 EYE SWELLING 850 0.0228
159 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1253 0.0228
160 LIVER FUNCTION TEST INCREASED 485 0.0226
161 RHEUMATOID FACTOR POSITIVE 130 0.0225
162 GAIT INABILITY 750 0.0224
163 MUSCLE SPASTICITY 273 0.0222
164 LIBIDO INCREASED 45 0.0222
165 PSORIATIC ARTHROPATHY 898 0.0221
166 INJECTION SITE INFLAMMATION 110 0.0221
167 C-REACTIVE PROTEIN INCREASED 795 0.0218
168 GESTATIONAL HYPERTENSION 28 0.0217
169 AUTOIMMUNE DISORDER 208 0.0213
170 EYELID PAIN 43 0.0211
171 OFF LABEL USE 18517 0.0211
172 IMPAIRED HEALING 693 0.0211
173 SEDATION 549 0.0209
174 INJECTION SITE SWELLING 1591 0.0207
175 MUSCLE TIGHTNESS 335 0.0207
176 NIGHT SWEATS 653 0.0202
177 PARADOXICAL DRUG REACTION 74 0.0201
178 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 27 0.0200
179 PRESCRIBED OVERDOSE 387 0.0200
180 THERAPEUTIC RESPONSE DELAYED 55 0.0196
181 CYSTITIS NONINFECTIVE 26 0.0194
182 PARALYSIS 271 0.0189
183 HEAD TITUBATION 26 0.0189
184 HYPERACUSIS 68 0.0183
185 ELECTRIC SHOCK SENSATION 51 0.0182
186 MUSCLE CONTRACTIONS INVOLUNTARY 63 0.0179
187 INFLAMMATION 920 0.0178
188 MUSCLE TWITCHING 408 0.0177
189 ABNORMAL SENSATION IN EYE 76 0.0177
190 MIGRAINE WITH AURA 48 0.0176
191 EXOSTOSIS 161 0.0176
192 INJECTION SITE NODULE 194 0.0176
193 PERSONALITY DISORDER 46 0.0175
194 TRISMUS 90 0.0174
195 OSTEOARTHRITIS 736 0.0173
196 HOSTILITY 44 0.0173
197 BREAST CANCER STAGE II 144 0.0173
198 MAST CELL ACTIVATION SYNDROME 24 0.0171
199 OTITIS MEDIA 56 0.0169
200 PARANASAL SINUS DISCOMFORT 64 0.0169
201 DRUG TOLERANCE 85 0.0168
202 INJECTION SITE RASH 515 0.0168
203 SUSPECTED COUNTERFEIT PRODUCT 66 0.0167
204 BLOOD CHOLESTEROL INCREASED 775 0.0166
205 HYPERTONIC BLADDER 48 0.0166
206 PHOTOPHOBIA 312 0.0166
207 SWELLING 1530 0.0163
208 DRY MOUTH 1320 0.0163
209 ARTHROPATHY 891 0.0160
210 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1138 0.0160
211 INJECTION SITE DISCOMFORT 168 0.0160
212 TRIGEMINAL NEURALGIA 64 0.0159
213 HYPOAESTHESIA ORAL 239 0.0158
214 INJECTION SITE ATROPHY 26 0.0158
215 NIGHTMARE 547 0.0158
216 MUSCULOSKELETAL PAIN 826 0.0158
217 TEMPOROMANDIBULAR JOINT SYNDROME 42 0.0157
218 DRUG INTOLERANCE 1501 0.0155
219 BLISTER 869 0.0155
220 MUSCLE ATROPHY 195 0.0154
221 LOWER RESPIRATORY TRACT INFECTION 699 0.0154
222 DROOLING 105 0.0152
223 PREGNANCY 304 0.0152
224 MATERNAL EXPOSURE TIMING UNSPECIFIED 57 0.0152
225 INJECTION RELATED REACTION 25 0.0151
226 DRUG-INDUCED LIVER INJURY 475 0.0151
227 DYSPHONIA 878 0.0150
228 PRODUCT STORAGE ERROR 1311 0.0150
229 HYPOAESTHESIA 2230 0.0149
230 EXCESSIVE EYE BLINKING 22 0.0149
231 NERVE INJURY 165 0.0148
232 EYE INJURY 45 0.0148
233 INJECTION SITE MASS 546 0.0148
234 HEPATITIS 371 0.0145
235 INFLUENZA LIKE ILLNESS 1191 0.0145
236 EAR DISCOMFORT 147 0.0143
237 PRODUCT DISTRIBUTION ISSUE 132 0.0142
238 CONCUSSION 110 0.0142
239 ULCER HAEMORRHAGE 95 0.0140
240 INJECTION SITE INFECTION 46 0.0140
241 MASS 195 0.0139
242 INJECTION SITE PAIN 4277 0.0139
243 AURA 26 0.0139
244 GASTROOESOPHAGEAL REFLUX DISEASE 1121 0.0139
245 NEUROGENIC BLADDER 29 0.0137
246 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152 0.0137
247 EYE MOVEMENT DISORDER 94 0.0137
248 TENDERNESS 143 0.0137
249 THERAPEUTIC PRODUCT EFFECT VARIABLE 53 0.0136
250 LUNG DISORDER 665 0.0136
251 MATERNAL EXPOSURE DURING PREGNANCY 1202 0.0135
252 EAR PAIN 262 0.0135
253 INDURATION 24 0.0135
254 ATROPHY 26 0.0134
255 OCULAR DISCOMFORT 150 0.0133
256 VISION BLURRED 1829 0.0133
257 SWOLLEN TONGUE 416 0.0133
258 NASAL OEDEMA 24 0.0133
259 INFUSION RELATED REACTION 879 0.0132
260 WHEEZING 772 0.0130
261 BLADDER PAIN 41 0.0129
262 MUSCULOSKELETAL STIFFNESS 1122 0.0128
263 STOMATITIS 772 0.0127
264 MUSCLE DISORDER 103 0.0127
265 DRY EYE 632 0.0126
266 URINARY RETENTION 418 0.0125
267 SINUS PAIN 29 0.0124
268 URINARY BLADDER HAEMORRHAGE 26 0.0123
269 EYE OEDEMA 30 0.0122
270 ERYTHEMA OF EYELID 66 0.0122
271 VOCAL CORD DISORDER 24 0.0122
272 PARESIS 27 0.0121
273 CHOKING SENSATION 66 0.0120
274 INJECTION SITE SCAR 34 0.0119
275 PARAESTHESIA 1877 0.0119
276 SPEECH DISORDER 617 0.0118
277 MONOPLEGIA 51 0.0117
278 NECK SURGERY 27 0.0116
279 INJECTION SITE URTICARIA 282 0.0115
280 NEPHROLITHIASIS 526 0.0115
281 NODULE 149 0.0114
282 THERAPEUTIC PRODUCT EFFECT DELAYED 52 0.0114
283 MOBILITY DECREASED 816 0.0113
284 SENSATION OF HEAVINESS 44 0.0113
285 INTENTIONAL PRODUCT USE ISSUE 992 0.0113
286 HYPOTONIA 112 0.0112
287 EYELID IRRITATION 28 0.0112
288 ASPIRATION 122 0.0111
289 HEPATIC ENZYME INCREASED 752 0.0110
290 DISCOMFORT 669 0.0110
291 THROAT TIGHTNESS 296 0.0109
292 LACRIMATION INCREASED 330 0.0109
293 EYELIDS PRURITUS 34 0.0109
294 VASCULAR OCCLUSION 23 0.0109
295 CHOKING 211 0.0108
296 RASH VESICULAR 52 0.0107
297 INJECTION SITE REACTION 737 0.0107
298 EYE DISCHARGE 111 0.0107
299 THERAPY NON-RESPONDER 479 0.0106
300 LUPUS-LIKE SYNDROME 96 0.0106
301 GUILLAIN-BARRE SYNDROME 51 0.0105
302 GENERAL PHYSICAL CONDITION ABNORMAL 71 0.0105
303 WALKING AID USER 69 0.0105
304 LIP PAIN 30 0.0104
305 DYSARTHRIA 392 0.0104
306 AUTONOMIC NERVOUS SYSTEM IMBALANCE 30 0.0103
307 EXOPHTHALMOS 22 0.0102
308 MUSCLE FATIGUE 43 0.0101
309 SLEEP DISORDER 710 0.0100
310 MYASTHENIA GRAVIS 81 0.0100
311 FINE MOTOR SKILL DYSFUNCTION 29 0.0100
312 DRUG TOLERANCE DECREASED 28 0.0100
313 BURNING SENSATION 699 0.0100
314 EXPOSURE DURING PREGNANCY 614 0.0099
315 SPINAL FUSION SURGERY 40 0.0098
316 SENSATION OF FOREIGN BODY 83 0.0098
317 SENSORY DISTURBANCE 158 0.0098
318 NEURALGIA 238 0.0098
319 INJECTION SITE VESICLES 59 0.0097
320 PRODUCT QUALITY ISSUE 1318 0.0097
321 HEADACHE 6048 0.0096
322 PUSTULAR PSORIASIS 33 0.0096
323 SKIN MASS 64 0.0096
324 VISUAL FIELD DEFECT 69 0.0095
325 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 62 0.0095
326 LOWER LIMB FRACTURE 183 0.0095
327 SLOW SPEECH 23 0.0095
328 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1919 0.0095
329 JOINT DISLOCATION 100 0.0095
330 BRAIN FOG 147 0.0094
331 URTICARIA 1557 0.0093
332 FOOD INTOLERANCE 34 0.0093
333 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 170 0.0093
334 IMPAIRED DRIVING ABILITY 105 0.0092
335 DRUG SPECIFIC ANTIBODY PRESENT 60 0.0092
336 DRUG ADMINISTERED AT INAPPROPRIATE SITE 97 0.0092
337 VITREOUS FLOATERS 90 0.0091
338 RHINALGIA 25 0.0091
339 URINARY INCONTINENCE 266 0.0090
340 BLEPHARITIS 36 0.0090
341 JAW DISORDER 49 0.0089
342 EYE DISORDER 294 0.0089
343 PHYSICAL DECONDITIONING 23 0.0089
344 MENOPAUSE 23 0.0089
345 TREATMENT FAILURE 737 0.0089
346 MATERNAL EXPOSURE DURING BREAST FEEDING 36 0.0089
347 STRIDOR 26 0.0088
348 LIP SWELLING 294 0.0088
349 EYE PAIN 498 0.0088
350 HYPERSENSITIVITY 1638 0.0088
351 CONTUSION 839 0.0087
352 VERTIGO 530 0.0087
353 AREFLEXIA 23 0.0086
354 PANIC REACTION 62 0.0086
355 PANIC ATTACK 313 0.0086
356 IMPAIRED WORK ABILITY 183 0.0086
357 OCCUPATIONAL EXPOSURE TO PRODUCT 55 0.0085
358 TINNITUS 391 0.0085
359 MUSCLE SPASMS 1557 0.0085
360 SCIATICA 135 0.0085
361 DEAFNESS UNILATERAL 46 0.0083
362 PHARYNGEAL DISORDER 24 0.0083
363 PRE-EXISTING CONDITION IMPROVED 52 0.0083
364 INJECTION SITE DISCOLOURATION 104 0.0083
365 HORDEOLUM 36 0.0083
366 SPONDYLITIS 30 0.0082
367 ILL-DEFINED DISORDER 500 0.0082
368 MEMORY IMPAIRMENT 1128 0.0082
369 INJURY 574 0.0082
370 ANGIOEDEMA 361 0.0082
371 BRUXISM 44 0.0082
372 RHEUMATOID ARTHRITIS 924 0.0081
373 PRODUCT USE IN UNAPPROVED INDICATION 2014 0.0081
374 PHOTOPSIA 51 0.0081
375 GENERAL PHYSICAL HEALTH DETERIORATION 930 0.0080
376 FOREIGN BODY SENSATION IN EYES 50 0.0078
377 PULMONARY FIBROSIS 150 0.0078
378 INJECTION SITE HAEMATOMA 113 0.0078
379 SKIN DISORDER 258 0.0077
380 INJECTION SITE ERYTHEMA 956 0.0077
381 DYSPEPSIA 748 0.0076
382 PAIN IN JAW 215 0.0076
383 MADAROSIS 88 0.0076
384 SINUS HEADACHE 45 0.0076
385 GRANULOMA 26 0.0075
386 BRAIN INJURY 75 0.0075
387 APHONIA 104 0.0074
388 FACE INJURY 28 0.0074
389 BLADDER DISORDER 73 0.0073
390 PARAESTHESIA ORAL 106 0.0073
391 INJECTION SITE BRUISING 584 0.0073
392 ANURIA 63 0.0073
393 INCORRECT PRODUCT STORAGE 96 0.0073
394 PRODUCT CONTAMINATION 26 0.0073
395 HYPERAESTHESIA 60 0.0073
396 PRESCRIBED UNDERDOSE 144 0.0072
397 PERONEAL NERVE PALSY 41 0.0072
398 GASTROINTESTINAL DISORDER 639 0.0071
399 RESPIRATORY DISORDER 212 0.0071
400 INJECTION SITE PRURITUS 474 0.0071
401 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 339 0.0071
402 CONFUSIONAL STATE 1131 0.0070
403 NEUROLOGICAL SYMPTOM 40 0.0070
404 JOINT STIFFNESS 183 0.0070
405 LEFT VENTRICULAR FAILURE 24 0.0070
406 HYPERHIDROSIS 898 0.0070
407 PAPULE 49 0.0069
408 BLINDNESS TRANSIENT 51 0.0069
409 FACE OEDEMA 116 0.0069
410 AUTOIMMUNE THYROIDITIS 26 0.0069
411 PRODUCT SUPPLY ISSUE 49 0.0069
412 DRUG RESISTANCE 176 0.0068
413 PRODUCT PACKAGING ISSUE 65 0.0068
414 MOUTH SWELLING 39 0.0068
415 MYOSITIS 60 0.0067
416 PRODUCT CONTAINER ISSUE 57 0.0066
417 HYPERTONIA 38 0.0066
418 JOINT SWELLING 800 0.0066
419 SKIN ODOUR ABNORMAL 26 0.0066
420 NYSTAGMUS 35 0.0066
421 MUSCULOSKELETAL DISCOMFORT 113 0.0066
422 ALOPECIA 1289 0.0066
423 MYDRIASIS 84 0.0065
424 SPINAL STENOSIS 27 0.0065
425 INCONTINENCE 69 0.0065
426 DEFORMITY 61 0.0065
427 APHASIA 196 0.0065
428 MICTURITION URGENCY 74 0.0065
429 SPINAL OPERATION 79 0.0064
430 INJECTION SITE INDURATION 83 0.0064
431 SALIVARY HYPERSECRETION 64 0.0064
432 PRODUCT ADMINISTRATION INTERRUPTED 50 0.0064
433 TONGUE DISORDER 46 0.0064
434 ASTHENIA 2389 0.0063
435 OROPHARYNGEAL DISCOMFORT 57 0.0063
436 EXPOSURE VIA BREAST MILK 25 0.0063
437 OESOPHAGEAL DISORDER 24 0.0062
438 PAROSMIA 47 0.0062
439 VISUAL IMPAIRMENT 771 0.0062
440 HAEMORRHAGE SUBCUTANEOUS 22 0.0062
441 SUSPECTED OFF LABEL USE 28 0.0062
442 DEPRESSION 1406 0.0062
443 ADVERSE DRUG REACTION 553 0.0062
444 DYSPHEMIA 27 0.0062
445 MUSCLE STRAIN 53 0.0061
446 DIZZINESS 3045 0.0061
447 OCULAR HYPERAEMIA 288 0.0061
448 PNEUMONIA ASPIRATION 151 0.0060
449 RASH PAPULAR 135 0.0060
450 IMPAIRED GASTRIC EMPTYING 82 0.0060
451 DISABILITY 118 0.0060
452 SENSORY LOSS 48 0.0060
453 HEPATIC CIRRHOSIS 112 0.0060
454 ABDOMINAL DISCOMFORT 996 0.0059
455 PHARYNGEAL SWELLING 58 0.0059
456 PARTIAL SEIZURES 31 0.0059
457 PHARYNGEAL OEDEMA 91 0.0059
458 HYPERTENSION 1252 0.0059
459 PERIPHERAL SWELLING 903 0.0059
460 ROAD TRAFFIC ACCIDENT 244 0.0058
461 DYSTONIA 112 0.0058
462 ABDOMINAL PAIN UPPER 1187 0.0058
463 EYE INFECTION 65 0.0058
464 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97 0.0057
465 SKIN HYPERPIGMENTATION 49 0.0057
466 EYE PRURITUS 191 0.0057
467 MUSCULOSKELETAL DISORDER 108 0.0057
468 PRESYNCOPE 137 0.0056
469 DRY THROAT 57 0.0056
470 SCAR 95 0.0055
471 SURGERY 323 0.0055
472 FEEDING DISORDER 111 0.0055
473 DYSGRAPHIA 36 0.0055
474 EYE OPERATION 25 0.0054
475 NASAL DISCOMFORT 43 0.0054
476 INJECTION SITE IRRITATION 69 0.0054
477 FOOT DEFORMITY 60 0.0054
478 ADVERSE EVENT 498 0.0054
479 BEDRIDDEN 71 0.0054
480 LYMPHADENOPATHY 191 0.0054
481 HERPES VIRUS INFECTION 31 0.0054
482 SHOULDER OPERATION 23 0.0054
483 NASOPHARYNGITIS 985 0.0053
484 UNDERDOSE 389 0.0053
485 SKIN WARM 31 0.0053
486 FEELING HOT 325 0.0053
487 MOTOR DYSFUNCTION 54 0.0053
488 ABDOMINAL DISTENSION 552 0.0053
489 INJECTION SITE INJURY 29 0.0052
490 ON AND OFF PHENOMENON 29 0.0052
491 PAIN 3192 0.0052
492 FOOD ALLERGY 40 0.0052
493 FORMICATION 36 0.0052
494 SINUSITIS 526 0.0051
495 DRUG EFFECT DECREASED 276 0.0051
496 SINUS DISORDER 101 0.0051
497 HEMIPARESIS 86 0.0051
498 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 361 0.0051
499 POST-TRAUMATIC STRESS DISORDER 34 0.0051
500 POOR QUALITY SLEEP 109 0.0051
501 GASTROINTESTINAL MOTILITY DISORDER 27 0.0050
502 DYSKINESIA 205 0.0050
503 WRONG PRODUCT ADMINISTERED 34 0.0050
504 PHOTOSENSITIVITY REACTION 83 0.0050
505 INTRACRANIAL PRESSURE INCREASED 28 0.0050
506 MATERNAL EXPOSURE BEFORE PREGNANCY 34 0.0050
507 ANXIETY 1412 0.0050
508 ROSACEA 23 0.0049
509 INCORRECT PRODUCT ADMINISTRATION DURATION 106 0.0049
510 ANAL INCONTINENCE 44 0.0049
511 SKIN DISCOLOURATION 224 0.0049
512 DYSSTASIA 142 0.0049
513 MOVEMENT DISORDER 156 0.0049
514 FEELING DRUNK 36 0.0048
515 SINUS CONGESTION 65 0.0048
516 GENERAL SYMPTOM 36 0.0048
517 AMNESIA 312 0.0048
518 LIMB OPERATION 23 0.0048
519 FAECAL INCONTINENCE 23 0.0048
520 HYDROCEPHALUS 26 0.0048
521 PALPITATIONS 558 0.0048
522 PRODUCT ADMINISTRATION ERROR 96 0.0047
523 OVERDOSE 1023 0.0047
524 UPPER RESPIRATORY TRACT INFECTION 218 0.0047
525 HORMONE LEVEL ABNORMAL 23 0.0047
526 CONDITION AGGRAVATED 1431 0.0047
527 ODYNOPHAGIA 28 0.0047
528 INSOMNIA 1249 0.0047
529 HYPOKINESIA 68 0.0047
530 INCREASED UPPER AIRWAY SECRETION 24 0.0047
531 DERMATITIS CONTACT 53 0.0046
532 ORAL DISORDER 34 0.0046
533 CYSTITIS 147 0.0046
534 INTENTIONAL PRODUCT MISUSE 404 0.0046
535 PRODUCT USE ISSUE 867 0.0046
536 FEELING OF BODY TEMPERATURE CHANGE 27 0.0046
537 TENSION 28 0.0046
538 VEIN DISORDER 23 0.0046
539 EAR INFECTION 122 0.0046
540 EYE IRRITATION 262 0.0045
541 RASH 1984 0.0045
542 TOOTHACHE 82 0.0045
543 SKIN ATROPHY 26 0.0045
544 MUSCLE RIGIDITY 54 0.0045
545 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
546 HYPERVENTILATION 26 0.0045
547 DYSPNOEA 2521 0.0044
548 ARTHROPOD BITE 33 0.0044
549 HEMIPLEGIA 37 0.0044
550 SPINAL PAIN 52 0.0044
551 BODY TEMPERATURE INCREASED 90 0.0044
552 ASTHMA 497 0.0044
553 ERYTHEMA 903 0.0044
554 HYSTERECTOMY 38 0.0044
555 BALANCE DISORDER 379 0.0044
556 NONSPECIFIC REACTION 24 0.0044
557 OROPHARYNGEAL PAIN 404 0.0044
558 INJECTION SITE WARMTH 89 0.0043
559 CEREBRAL DISORDER 32 0.0043
560 SPINAL OSTEOARTHRITIS 38 0.0043
561 FEELING ABNORMAL 1035 0.0043
562 IMPAIRED QUALITY OF LIFE 62 0.0043
563 DISTURBANCE IN ATTENTION 232 0.0043
564 WEIGHT FLUCTUATION 45 0.0043
565 PALLOR 117 0.0043
566 NAUSEA 3398 0.0043
567 WEIGHT INCREASED 961 0.0043
568 MIDDLE INSOMNIA 80 0.0043
569 THERAPEUTIC RESPONSE UNEXPECTED 191 0.0043
570 CHEILITIS 23 0.0042
571 ORAL DISCOMFORT 59 0.0042
572 PRODUCT DISPENSING ERROR 92 0.0042
573 OEDEMA 229 0.0042
574 POST PROCEDURAL COMPLICATION 81 0.0042
575 INTERVERTEBRAL DISC DEGENERATION 39 0.0042
576 LIMB DISCOMFORT 130 0.0042
577 INSURANCE ISSUE 64 0.0042
578 VISUAL ACUITY REDUCED 139 0.0042
579 HIP ARTHROPLASTY 64 0.0042
580 THERAPY PARTIAL RESPONDER 65 0.0042
581 GAIT DISTURBANCE 796 0.0042
582 TREMOR 690 0.0042
583 CHEST DISCOMFORT 425 0.0041
584 SLEEP APNOEA SYNDROME 79 0.0041
585 BRAIN NEOPLASM 38 0.0041
586 MULTIPLE SCLEROSIS 197 0.0041
587 RASH PUSTULAR 30 0.0041
588 FOOD POISONING 22 0.0041
589 INCORRECT ROUTE OF DRUG ADMINISTRATION 146 0.0041
590 MULTIPLE ALLERGIES 32 0.0041
591 SEIZURE 469 0.0041
592 SCOLIOSIS 25 0.0040
593 URINARY TRACT INFECTION 688 0.0040
594 SKIN SWELLING 35 0.0040
595 CYST 50 0.0040
596 NASAL DRYNESS 25 0.0040
597 SEASONAL ALLERGY 56 0.0040
598 SCAB 45 0.0039
599 ARTERIOSCLEROSIS CORONARY ARTERY 26 0.0039
600 FATIGUE 3037 0.0039
601 NERVE COMPRESSION 36 0.0039
602 GINGIVAL PAIN 31 0.0039
603 ACTIVITIES OF DAILY LIVING IMPAIRED 77 0.0039
604 SYMPTOM RECURRENCE 23 0.0038
605 THROAT IRRITATION 172 0.0038
606 PRODUCT LABEL ISSUE 26 0.0038
607 BLINDNESS UNILATERAL 54 0.0038
608 IMMUNODEFICIENCY 57 0.0038
609 BACK DISORDER 62 0.0038
610 DYSURIA 140 0.0038
611 KNEE ARTHROPLASTY 80 0.0038
612 RIB FRACTURE 78 0.0038
613 TEMPERATURE INTOLERANCE 39 0.0038
614 VOMITING 1775 0.0038
615 MALAISE 1653 0.0038
616 SECRETION DISCHARGE 47 0.0037
617 DELIRIUM 130 0.0037
618 MENSTRUAL DISORDER 31 0.0037
619 PRODUCT PHYSICAL ISSUE 75 0.0037
620 NERVOUS SYSTEM DISORDER 116 0.0037
621 UNEVALUABLE EVENT 281 0.0037
622 PAIN IN EXTREMITY 1094 0.0037
623 INITIAL INSOMNIA 38 0.0037
624 ANAPHYLACTIC REACTION 204 0.0037
625 COLD SWEAT 65 0.0037
626 VIRAL INFECTION 122 0.0037
627 EATING DISORDER 78 0.0037
628 ANOSMIA 53 0.0037
629 PERIPHERAL COLDNESS 50 0.0036
630 VITAMIN D DECREASED 31 0.0036
631 INJECTION SITE HAEMORRHAGE 289 0.0036
632 FALL 1204 0.0036
633 SNEEZING 81 0.0036
634 FOETAL EXPOSURE DURING PREGNANCY 293 0.0036
635 FREQUENT BOWEL MOVEMENTS 97 0.0036
636 POST PROCEDURAL INFECTION 29 0.0036
637 EYE INFLAMMATION 34 0.0036
638 BLINDNESS 145 0.0036
639 LOCAL SWELLING 62 0.0036
640 MYALGIA 604 0.0035
641 DENTAL CARIES 39 0.0035
642 PNEUMONIA 1136 0.0035
643 ARTHRALGIA 1457 0.0035
644 DRUG EFFECT INCOMPLETE 127 0.0035
645 LETHARGY 200 0.0035
646 APNOEA 27 0.0035
647 OSTEOPOROSIS 142 0.0034
648 RASH ERYTHEMATOUS 165 0.0034
649 HERPES ZOSTER 198 0.0034
650 HEAD INJURY 109 0.0034
651 DECUBITUS ULCER 28 0.0034
652 INTERVERTEBRAL DISC PROTRUSION 75 0.0034
653 ASPHYXIA 28 0.0034
654 MENTAL IMPAIRMENT 83 0.0034
655 SKIN LACERATION 37 0.0034
656 PROCEDURAL COMPLICATION 26 0.0034
657 PRURITUS GENERALISED 73 0.0034
658 HEART RATE INCREASED 331 0.0033
659 BIPOLAR DISORDER 36 0.0033
660 LIQUID PRODUCT PHYSICAL ISSUE 24 0.0033
661 ATAXIA 39 0.0033
662 CHEST PAIN 608 0.0033
663 RETINAL DETACHMENT 30 0.0033
664 UROSEPSIS 30 0.0032
665 COGNITIVE DISORDER 151 0.0032
666 RESPIRATORY TRACT INFECTION 84 0.0032
667 FRUSTRATION TOLERANCE DECREASED 26 0.0032
668 WEIGHT DECREASED 894 0.0032
669 DIZZINESS POSTURAL 31 0.0032
670 LOSS OF CONSCIOUSNESS 409 0.0032
671 IMMUNE SYSTEM DISORDER 42 0.0032
672 ILLNESS 327 0.0032
673 PRODUCT COMPLAINT 80 0.0032
674 ARTHRITIS 247 0.0031
675 RESTLESS LEGS SYNDROME 57 0.0031
676 THIRST 56 0.0031
677 DISORIENTATION 124 0.0031
678 RASH GENERALISED 81 0.0031
679 SENSITIVE SKIN 23 0.0031
680 THINKING ABNORMAL 58 0.0031
681 EXTRAPYRAMIDAL DISORDER 77 0.0031
682 DEAFNESS 81 0.0031
683 ACCIDENTAL EXPOSURE TO PRODUCT 318 0.0031
684 TOOTH FRACTURE 34 0.0031
685 LACERATION 29 0.0031
686 CONJUNCTIVITIS 57 0.0031
687 DYSGEUSIA 228 0.0031
688 PRURITUS 1179 0.0031
689 KNEE OPERATION 30 0.0030
690 SKIN INFECTION 34 0.0030
691 NEPHROPATHY TOXIC 34 0.0030
692 HEART RATE IRREGULAR 68 0.0030
693 KIDNEY INFECTION 59 0.0030
694 CARPAL TUNNEL SYNDROME 42 0.0030
695 THYROID DISORDER 46 0.0030
696 VITAMIN D DEFICIENCY 29 0.0030
697 PHARYNGITIS STREPTOCOCCAL 32 0.0030
698 INFUSION SITE PAIN 38 0.0029
699 POISONING 37 0.0029
700 FEAR 79 0.0029
701 CELLULITIS 148 0.0029
702 PAIN OF SKIN 79 0.0029
703 LIGAMENT SPRAIN 29 0.0029
704 AGEUSIA 73 0.0029
705 RENAL PAIN 31 0.0029
706 ABORTION SPONTANEOUS 117 0.0029
707 CRYING 106 0.0029
708 PYREXIA 1008 0.0029
709 INFLUENZA 319 0.0029
710 DECREASED APPETITE 660 0.0028
711 CHILLS 333 0.0028
712 FEELING COLD 79 0.0028
713 BACK PAIN 656 0.0028
714 FLUSHING 284 0.0028
715 SYNCOPE 279 0.0028
716 DERMATITIS ALLERGIC 35 0.0028
717 GENERALISED TONIC-CLONIC SEIZURE 46 0.0028
718 RESPIRATORY TRACT CONGESTION 44 0.0028
719 EXPIRED PRODUCT ADMINISTERED 92 0.0028
720 SEROTONIN SYNDROME 53 0.0028
721 CEREBROVASCULAR ACCIDENT 466 0.0027
722 IMMUNOSUPPRESSION 24 0.0027
723 INCREASED TENDENCY TO BRUISE 25 0.0027
724 CHOLECYSTECTOMY 31 0.0027
725 NASAL CONGESTION 158 0.0027
726 GASTROENTERITIS VIRAL 48 0.0027
727 PNEUMOTHORAX 42 0.0026
728 BRONCHITIS 196 0.0026
729 MEDICATION ERROR 147 0.0026
730 TACHYCARDIA 234 0.0026
731 SKIN REACTION 37 0.0026
732 ORAL HERPES 51 0.0026
733 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
734 WHITE BLOOD CELL COUNT INCREASED 100 0.0026
735 IRON DEFICIENCY ANAEMIA 24 0.0026
736 RHINORRHOEA 168 0.0026
737 LIVER DISORDER 115 0.0026
738 POLLAKIURIA 108 0.0026
739 TRANSIENT ISCHAEMIC ATTACK 87 0.0026
740 DERMATITIS 54 0.0026
741 SOMNOLENCE 516 0.0026
742 APPLICATION SITE PAIN 56 0.0025
743 DEPRESSED MOOD 134 0.0025
744 MYOCLONUS 30 0.0025
745 COVID-19 441 0.0025
746 ABASIA 62 0.0025
747 CONSTIPATION 540 0.0025
748 APPENDICITIS 23 0.0025
749 INFECTION 356 0.0025
750 OBSTRUCTIVE AIRWAYS DISORDER 27 0.0024
751 PHARYNGITIS 30 0.0024
752 BACTERIAL INFECTION 45 0.0024
753 RASH PRURITIC 130 0.0024
754 ADRENAL INSUFFICIENCY 29 0.0024
755 MENTAL DISORDER 104 0.0024
756 ABDOMINAL PAIN 555 0.0024
757 QUALITY OF LIFE DECREASED 32 0.0024
758 FOOT FRACTURE 45 0.0024
759 ORAL PAIN 53 0.0024
760 PELVIC PAIN 43 0.0024
761 SUDDEN DEATH 25 0.0024
762 SUICIDAL IDEATION 216 0.0024
763 HAEMATOMA 61 0.0024
764 MULTIPLE SCLEROSIS RELAPSE 161 0.0023
765 ANGINA PECTORIS 67 0.0023
766 NERVOUSNESS 122 0.0023
767 CENTRAL NERVOUS SYSTEM LESION 32 0.0023
768 DEPRESSED LEVEL OF CONSCIOUSNESS 92 0.0023
769 EYE HAEMORRHAGE 31 0.0023
770 RESPIRATORY DISTRESS 64 0.0023
771 VENTRICULAR EXTRASYSTOLES 24 0.0023
772 HYPOPHAGIA 59 0.0023
773 HAEMORRHOIDS 45 0.0023
774 STATUS EPILEPTICUS 26 0.0023
775 RETCHING 49 0.0023
776 DIARRHOEA 1481 0.0023
777 ANAPHYLACTIC SHOCK 59 0.0023
778 DEATH 1958 0.0023
779 INJECTION SITE EXTRAVASATION 28 0.0023
780 BLOOD PRESSURE INCREASED 346 0.0023
781 ACCIDENT 27 0.0023
782 ROTATOR CUFF SYNDROME 29 0.0023
783 LIMB INJURY 61 0.0022
784 HYPOACUSIS 96 0.0022
785 COORDINATION ABNORMAL 31 0.0022
786 LYMPHOCYTE COUNT DECREASED 39 0.0022
787 ACNE 167 0.0022
788 THERAPY CESSATION 113 0.0022
789 TOOTH INFECTION 29 0.0022
790 MUSCULOSKELETAL CHEST PAIN 34 0.0022
791 HEART RATE DECREASED 77 0.0022
792 HYPOTHYROIDISM 70 0.0022
793 GASTROINTESTINAL PAIN 24 0.0022
794 HIATUS HERNIA 28 0.0022
795 CYANOSIS 34 0.0022
796 TOOTH DISORDER 48 0.0022
797 SKIN LESION 59 0.0021
798 MALNUTRITION 24 0.0021
799 INCORRECT DOSE ADMINISTERED 486 0.0021
800 MACULAR DEGENERATION 25 0.0021
801 RASH MACULAR 73 0.0021
802 NEOPLASM 24 0.0021
803 GLAUCOMA 40 0.0021
804 COUGH 579 0.0021
805 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371 0.0021
806 HOSPITALISATION 306 0.0020
807 RESPIRATORY FAILURE 145 0.0020
808 PROCEDURAL PAIN 55 0.0020
809 ECONOMIC PROBLEM 30 0.0020
810 EMOTIONAL DISORDER 61 0.0020
811 RECTAL HAEMORRHAGE 85 0.0020
812 OXYGEN SATURATION DECREASED 111 0.0020
813 NO THERAPEUTIC RESPONSE 24 0.0020
814 LABORATORY TEST ABNORMAL 58 0.0020
815 CANDIDA INFECTION 33 0.0020
816 HYPERSOMNIA 56 0.0020
817 IRRITABILITY 117 0.0019
818 MOOD ALTERED 53 0.0019
819 TENDONITIS 30 0.0019
820 NOCTURIA 23 0.0019
821 BLOOD PRESSURE FLUCTUATION 45 0.0019
822 JOINT INJURY 40 0.0019
823 PRODUCTIVE COUGH 89 0.0019
824 DRUG ERUPTION 33 0.0019
825 HERNIA 36 0.0019
826 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 54 0.0018
827 BLOOD PRESSURE DECREASED 122 0.0018
828 CHRONIC KIDNEY DISEASE 139 0.0018
829 BLOOD POTASSIUM DECREASED 54 0.0018
830 HAIR TEXTURE ABNORMAL 24 0.0018
831 DEVICE DIFFICULT TO USE 118 0.0018
832 RESPIRATORY ARREST 49 0.0018
833 NEOPLASM MALIGNANT 118 0.0018
834 CONVULSION 100 0.0017
835 FUNGAL INFECTION 58 0.0017
836 DIVERTICULITIS 48 0.0017
837 HALLUCINATION 128 0.0017
838 STAPHYLOCOCCAL INFECTION 56 0.0017
839 ULCER 27 0.0017
840 OEDEMA PERIPHERAL 206 0.0017
841 DRUG TOXICITY 23 0.0017
842 BLOOD URINE PRESENT 32 0.0017
843 CATARACT 100 0.0017
844 FEELING JITTERY 32 0.0017
845 CEREBRAL INFARCTION 41 0.0017
846 GASTRITIS 44 0.0017
847 MOUTH ULCERATION 35 0.0017
848 HOT FLUSH 125 0.0017
849 BONE PAIN 97 0.0017
850 GASTROENTERITIS 24 0.0016
851 HAEMATURIA 56 0.0016
852 INJURY ASSOCIATED WITH DEVICE 33 0.0016
853 PSORIASIS 211 0.0016
854 HYPOTENSION 324 0.0016
855 NEUROPATHY PERIPHERAL 151 0.0016
856 PRODUCT USE COMPLAINT 25 0.0016
857 HIP FRACTURE 51 0.0016
858 SKIN BURNING SENSATION 112 0.0016
859 PRODUCT DOSE OMISSION 102 0.0016
860 UPPER LIMB FRACTURE 31 0.0016
861 SKIN HAEMORRHAGE 23 0.0016
862 ANKLE FRACTURE 24 0.0015
863 UNRESPONSIVE TO STIMULI 40 0.0015
864 CARDIAC DISORDER 145 0.0015
865 COLITIS ULCERATIVE 69 0.0015
866 DEHYDRATION 205 0.0015
867 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
868 FLUID RETENTION 77 0.0015
869 PANCREATITIS 80 0.0015
870 BLOOD PRESSURE ABNORMAL 30 0.0015
871 INTENTIONAL DOSE OMISSION 43 0.0015
872 BREAST CANCER FEMALE 40 0.0015
873 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
874 ARRHYTHMIA 70 0.0015
875 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
876 GASTRIC ULCER 28 0.0015
877 ACUTE RESPIRATORY FAILURE 28 0.0015
878 SPINAL FRACTURE 29 0.0014
879 CHOLELITHIASIS 47 0.0014
880 DEMENTIA 40 0.0014
881 CEREBRAL HAEMORRHAGE 51 0.0014
882 SKIN IRRITATION 65 0.0014
883 SKIN EXFOLIATION 119 0.0014
884 DYSPNOEA EXERTIONAL 53 0.0014
885 LOCALISED INFECTION 34 0.0014
886 THERAPY INTERRUPTED 100 0.0014
887 ORTHOSTATIC HYPOTENSION 24 0.0014
888 FRACTURE 26 0.0014
889 GASTRIC DISORDER 47 0.0014
890 PREMATURE BABY 41 0.0014
891 ECZEMA 71 0.0014
892 INTESTINAL OBSTRUCTION 51 0.0014
893 SKIN CANCER 28 0.0013
894 APPLICATION SITE ERYTHEMA 34 0.0013
895 CIRCULATORY COLLAPSE 22 0.0013
896 PRODUCT PRESCRIBING ISSUE 28 0.0013
897 ANGER 43 0.0013
898 SEPSIS 141 0.0013
899 PRODUCT DOSE OMISSION ISSUE 371 0.0013
900 TOOTH LOSS 26 0.0013
901 DRUG DOSE OMISSION BY DEVICE 98 0.0013
902 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
903 ABNORMAL DREAMS 33 0.0012
904 BRADYCARDIA 63 0.0012
905 PRODUCT AVAILABILITY ISSUE 27 0.0012
906 RESTLESSNESS 43 0.0012
907 HAEMORRHAGE 121 0.0012
908 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
909 WITHDRAWAL SYNDROME 48 0.0011
910 BREAST CANCER 106 0.0011
911 NEEDLE ISSUE 33 0.0011
912 DRUG INTERACTION 179 0.0011
913 SEPTIC SHOCK 48 0.0011
914 APPLICATION SITE PRURITUS 25 0.0011
915 TARDIVE DYSKINESIA 31 0.0011
916 FEMUR FRACTURE 34 0.0011
917 DRY SKIN 146 0.0011
918 ABNORMAL BEHAVIOUR 43 0.0011
919 AGITATION 79 0.0011
920 ABDOMINAL PAIN LOWER 27 0.0011
921 MOOD SWINGS 34 0.0011
922 EMOTIONAL DISTRESS 129 0.0011
923 HYPOKALAEMIA 49 0.0011
924 COMA 50 0.0010
925 THROMBOSIS 84 0.0010
926 DRUG ADMINISTRATION ERROR 32 0.0010
927 PULMONARY EMBOLISM 98 0.0010
928 TOXICITY TO VARIOUS AGENTS 171 0.0010
929 ACCIDENTAL OVERDOSE 37 0.0010
930 PRODUCT PRESCRIBING ERROR 24 0.0010
931 ATRIAL FIBRILLATION 98 0.0010
932 RENAL DISORDER 46 0.0010
933 CARDIO-RESPIRATORY ARREST 41 0.0010
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33 0.0010
935 SKIN ULCER 25 0.0010
936 EXPOSURE VIA SKIN CONTACT 25 0.0010
937 DEVICE ISSUE 86 0.0010
938 TREATMENT NONCOMPLIANCE 51 0.0009
939 WHITE BLOOD CELL COUNT DECREASED 101 0.0009
940 DEEP VEIN THROMBOSIS 60 0.0009
941 CARDIOVASCULAR DISORDER 23 0.0009
942 NO ADVERSE EVENT 164 0.0009
943 MENTAL STATUS CHANGES 25 0.0009
944 HYPOXIA 31 0.0009
945 EPISTAXIS 64 0.0009
946 DIABETES MELLITUS 65 0.0009
947 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
948 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
949 PSYCHOTIC DISORDER 25 0.0008
950 RED BLOOD CELL COUNT DECREASED 24 0.0008
951 HYPOGLYCAEMIA 39 0.0008
952 CARDIAC ARREST 66 0.0008
953 FLATULENCE 45 0.0008
954 RHABDOMYOLYSIS 33 0.0008
955 LEUKOPENIA 39 0.0008
956 HEPATIC FUNCTION ABNORMAL 29 0.0008
957 DEVICE MALFUNCTION 53 0.0008
958 DEVICE BREAKAGE 29 0.0007
959 BLOOD GLUCOSE DECREASED 34 0.0007
960 DERMATITIS ATOPIC 37 0.0007
961 HYPONATRAEMIA 39 0.0007
962 DEVICE DISLOCATION 30 0.0007
963 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
964 MYOCARDIAL INFARCTION 120 0.0007
965 COLITIS 26 0.0007
966 VAGINAL HAEMORRHAGE 29 0.0007
967 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
968 HAEMOGLOBIN DECREASED 60 0.0006
969 ANAEMIA 109 0.0006
970 EXTRA DOSE ADMINISTERED 23 0.0006
971 PULMONARY OEDEMA 25 0.0006
972 DRUG ABUSE 46 0.0006
973 CARDIAC FAILURE 44 0.0005
974 HAEMATOCHEZIA 30 0.0005
975 PLEURAL EFFUSION 33 0.0005
976 AGGRESSION 26 0.0005
977 DRUG DOSE OMISSION 81 0.0005
978 PRODUCT SUBSTITUTION ISSUE 28 0.0005
979 BLOOD CREATININE INCREASED 30 0.0005
980 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
981 DRUG WITHDRAWAL SYNDROME 37 0.0004
982 SUICIDE ATTEMPT 24 0.0004
983 RENAL FAILURE 50 0.0004
984 BLOOD GLUCOSE INCREASED 67 0.0004
985 CARDIAC FAILURE CONGESTIVE 28 0.0003
986 DISEASE PROGRESSION 39 0.0003
987 RENAL IMPAIRMENT 27 0.0003
988 ACUTE KIDNEY INJURY 49 0.0003
989 PLATELET COUNT DECREASED 33 0.0003
990 DRUG DEPENDENCE 45 0.0003
991 THROMBOCYTOPENIA 24 0.0002